Company: STAA
Filing Date: 2025-10-02
Form Type: DFAN14A
Source: 0001213900-25-095514
Chunk: 28

Company: STAAR SURGICAL CO
Filing Date: 2025-10-02
Form: DFAN14A
Chunk 28
---
 provide these parties with information or access to management and did not invite them to submit proposals until just hours before the Merger Agreement was signed, aft er the sale process was effectively over. 6 5 3 2 2 2 0 0 BioTelemetry Silk Road Medical K2M Group Holdings Wright Medical Group LENSAR Cardiovascular Systems Cantel Medical STAAR Surgical² Philips (2020) Boston Scientific (2024) Stryker (2018) Stryker (2019) Alcon (2025) Abbott Labs (2023) STERIS (2021) Alcon (2025) Target Acquirer

Broadwood Partners, L.P. The Board’s Rationale for Conducting a Limited Process Is Unavailing 39 1 We believe the Board erred by not conducting a more fulsome process that stoked demand and maximized competitive tension Broadwood’s Response STAAR’s Rationale for Not Conducting Outreach ▪ In our view, the Board’s focus should have been on maximizing the value of the Company in a sale, not sparing the Board and management team from the supposed inconvenience of needing to engage with other parties ▪ We believe the incremental “disruption” from private outreach to a select group of potential acquirers would be minimal and, in all events, would largely be borne by the Company’s financial advisor “[D] isruption … could result from exploratory outreaches…” 1 ▪ At the time Alcon indicated its renewed interest in acquiring STAAR in June 2025, the Company’s stock was trading near multi - year lows, making STAAR an attractive target ▪ We believe many parties would have been interested in acquiring STAAR at such a depressed valuation, had they been aware the Company was exploring a sale ▪ We are aware of a CEO of a well - capitalized and leading ophthalmology company who reached out to the STAAR’s CEO and Chair in April 2025 seeking to discuss a strategic transaction; he was entirely ignored, and his interest was not disclosed in the Company’s proxy statement “[F] ollowing the market rumors in July 2024 that STAAR was attracting takeover interest, no potential buyers had approached STAAR.” 2 ▪ The interest from Party A and Party B disclosed in the Company’s proxy statement reinforces our view that there is a ready pool of credible, well - capitalized potential buyers for STAAR ▪ We know of, and have spoken with, several parties – in addition to Party